Drug Trial Radar · NCT01192568
Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
Last checked: Nov 20, 2026Latest source record: Sep 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
May 17, 2011
Primary completion
Aug 29, 2023
Study completion Oct 24, 2023
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Sep 1, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of Oxybutynin Chloride 10% Topical Gel in children 3 to less than 17 years old, who have overactive bladder due to a neurogenic condition. Children will be treated with 0.75 g of gel/day for two weeks. Patients will then return to the clinic for a potential dose titration. At this time their dose may be adjusted up to 1g/day, down to 0.5g/day, or remain the same at 0.75g of gel/day depending on the individual response and tolerability. The total treatment time is 14 weeks and total time on the study is 16 weeks.
Conditions
- Overactive Detrusor
- Neurogenic Bladder
Interventions
OxybutyninDrug
10% Oxybutynin Chloride Topical Gel, 0.5 g, 0.75 g, and 1 g/day, administered transdermally.
PlaceboDrug
Topical gel
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Percent of Catheterizations Without a Leaking Accident at Week 6Time frame: Baseline (Week 0) up to Week 6
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Loma Linda University /ID# 236889
Loma Linda, California
Child Hosp of Orange County,CA /ID# 237517
Orange, California
Children's Hospital Colorado - Aurora /ID# 237620
Aurora, Colorado
Augusta University Medical Center /ID# 238188
Augusta, Georgia
University of Mississippi Medical Center /ID# 238065
Jackson, Mississippi
Albany Medical College /ID# 236880
Albany, New York
Duke University /ID# 237494
Durham, North Carolina
Duplicate_Oregon Health & Science University /ID# 234354
Portland, Oregon
Cook Children's Med. Center /ID# 237538
Fort Worth, Texas
Child Hosp of the King's Dtr's /ID# 237799
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.